Cargando…

Preservation of red blood cell antigenicity in a new storage solution in vitro

INTRODUCTION: Red blood cell (RBC) storage solution is used for suspending and preserving RBCs for later use in in vitro immunohematology testing. Proper RBC preservation is crucial for obtaining accurate results in RBC phenotyping and pretransfusion antibody screening tests. Haemolysis or RBC antig...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Sheng-Hui, Lin, Hsin-Chung, Chang, Jin-Biou, Chan, Yung-Shu, Tang, Hui-Fei, Chang, Feng-Yee, Chiueh, Tzong-Shi, Yang, Bing-Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762792/
https://www.ncbi.nlm.nih.gov/pubmed/36519679
http://dx.doi.org/10.1080/07853890.2022.2157476
_version_ 1784852930814279680
author Tang, Sheng-Hui
Lin, Hsin-Chung
Chang, Jin-Biou
Chan, Yung-Shu
Tang, Hui-Fei
Chang, Feng-Yee
Chiueh, Tzong-Shi
Yang, Bing-Heng
author_facet Tang, Sheng-Hui
Lin, Hsin-Chung
Chang, Jin-Biou
Chan, Yung-Shu
Tang, Hui-Fei
Chang, Feng-Yee
Chiueh, Tzong-Shi
Yang, Bing-Heng
author_sort Tang, Sheng-Hui
collection PubMed
description INTRODUCTION: Red blood cell (RBC) storage solution is used for suspending and preserving RBCs for later use in in vitro immunohematology testing. Proper RBC preservation is crucial for obtaining accurate results in RBC phenotyping and pretransfusion antibody screening tests. Haemolysis or RBC antigen degradation during storage can result in inaccurate RBC phenotyping, thereby decreasing the sensitivity of pretransfusion antibody screening and identification assays. The conventional RBC storage solutions usually contain adenosine, adenine, and antibiotics. We designed an RBC storage solution and determined whether it could preserve RBC integrity for 70 days. MATERIALS AND METHODS: The new storage solution has a different formula from that of the conventional solution—in particular, it is strengthened with polyethylene glycol (PEG). The extent of haemolysis and hemagglutination reactivity of the RBC antigen systems, Rh, Duffy, Kidd, Lewis, MNS, P1, and the rare antigen Mi(a) (which has a low prevalence antigen in most parts of the world but a higher prevalence in Taiwan), in the new RBC storage solution was compared with that of the conventionally preserved RBC storage solution. RESULTS: The RBCs preserved in the new solution for 70 days retained a similar haemolysis grade as those preserved in the control solution for 28 days. Although both solutions largely preserved RBC antigenicity, the decline in RBC hemagglutination scores in new solution often occurred later than that in the control solution in most antigen phenotyping assays, especially labile antigens such as D, P1, and M. CONCLUSION: The new solution reduces haemolysis more effectively and preserves antigenicity throughout the 70-day storage period. Moreover, Mi(a) antigen is more stable in the experimental group.
format Online
Article
Text
id pubmed-9762792
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-97627922022-12-20 Preservation of red blood cell antigenicity in a new storage solution in vitro Tang, Sheng-Hui Lin, Hsin-Chung Chang, Jin-Biou Chan, Yung-Shu Tang, Hui-Fei Chang, Feng-Yee Chiueh, Tzong-Shi Yang, Bing-Heng Ann Med Clinical Pathology INTRODUCTION: Red blood cell (RBC) storage solution is used for suspending and preserving RBCs for later use in in vitro immunohematology testing. Proper RBC preservation is crucial for obtaining accurate results in RBC phenotyping and pretransfusion antibody screening tests. Haemolysis or RBC antigen degradation during storage can result in inaccurate RBC phenotyping, thereby decreasing the sensitivity of pretransfusion antibody screening and identification assays. The conventional RBC storage solutions usually contain adenosine, adenine, and antibiotics. We designed an RBC storage solution and determined whether it could preserve RBC integrity for 70 days. MATERIALS AND METHODS: The new storage solution has a different formula from that of the conventional solution—in particular, it is strengthened with polyethylene glycol (PEG). The extent of haemolysis and hemagglutination reactivity of the RBC antigen systems, Rh, Duffy, Kidd, Lewis, MNS, P1, and the rare antigen Mi(a) (which has a low prevalence antigen in most parts of the world but a higher prevalence in Taiwan), in the new RBC storage solution was compared with that of the conventionally preserved RBC storage solution. RESULTS: The RBCs preserved in the new solution for 70 days retained a similar haemolysis grade as those preserved in the control solution for 28 days. Although both solutions largely preserved RBC antigenicity, the decline in RBC hemagglutination scores in new solution often occurred later than that in the control solution in most antigen phenotyping assays, especially labile antigens such as D, P1, and M. CONCLUSION: The new solution reduces haemolysis more effectively and preserves antigenicity throughout the 70-day storage period. Moreover, Mi(a) antigen is more stable in the experimental group. Taylor & Francis 2022-12-15 /pmc/articles/PMC9762792/ /pubmed/36519679 http://dx.doi.org/10.1080/07853890.2022.2157476 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Pathology
Tang, Sheng-Hui
Lin, Hsin-Chung
Chang, Jin-Biou
Chan, Yung-Shu
Tang, Hui-Fei
Chang, Feng-Yee
Chiueh, Tzong-Shi
Yang, Bing-Heng
Preservation of red blood cell antigenicity in a new storage solution in vitro
title Preservation of red blood cell antigenicity in a new storage solution in vitro
title_full Preservation of red blood cell antigenicity in a new storage solution in vitro
title_fullStr Preservation of red blood cell antigenicity in a new storage solution in vitro
title_full_unstemmed Preservation of red blood cell antigenicity in a new storage solution in vitro
title_short Preservation of red blood cell antigenicity in a new storage solution in vitro
title_sort preservation of red blood cell antigenicity in a new storage solution in vitro
topic Clinical Pathology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762792/
https://www.ncbi.nlm.nih.gov/pubmed/36519679
http://dx.doi.org/10.1080/07853890.2022.2157476
work_keys_str_mv AT tangshenghui preservationofredbloodcellantigenicityinanewstoragesolutioninvitro
AT linhsinchung preservationofredbloodcellantigenicityinanewstoragesolutioninvitro
AT changjinbiou preservationofredbloodcellantigenicityinanewstoragesolutioninvitro
AT chanyungshu preservationofredbloodcellantigenicityinanewstoragesolutioninvitro
AT tanghuifei preservationofredbloodcellantigenicityinanewstoragesolutioninvitro
AT changfengyee preservationofredbloodcellantigenicityinanewstoragesolutioninvitro
AT chiuehtzongshi preservationofredbloodcellantigenicityinanewstoragesolutioninvitro
AT yangbingheng preservationofredbloodcellantigenicityinanewstoragesolutioninvitro